Blood-brain barrier disruption using electrical energy
The present invention provides methods, devices, and systems for in vivo treatment of cell proliferative disorders. Included is a method of treating tissue with electrical energy, the method comprising: delivering electrical energy to tissue using one or more electroporation devices comprising one or more electrodes; and cooling the tissue, surrounding tissue, one or more of the electrodes, or one or more of the electroporation devices to minimize heating. In embodiments, the invention can be used to treat solid tumors, such as brain tumors, and in some embodiments, exemplary methods rely on non-thermal irreversible electroporation (IRE) to cause cell death in treated tumors.
1. A method for treating brain tissue comprising:
inserting a probe into a target zone of a patient, wherein the probe comprises at least one electrode;
applying a plurality of electrical pulses through the at least one electrode, wherein the plurality of electrical pulses are configured to create an irreversible electroporation (IRE) decellularization zone causing a disruption of a blood-brain-barrier to the IRE decellularization zone, and wherein the plurality of electrical pulses are configured such that at least one pulse has a positive polarity and at least one pulse has a negative polarity; and
delivering an agent to the patient.
2. The method of claim 1 , wherein the probe further comprises at least a second electrode.
3. The method of claim 1 , wherein the probe further comprises at least a second electrode, wherein the second electrode is configured to be a surface electrode.
4. The method of claim 1 , wherein one or more pulses of the plurality of electrical pulses is configured to have an applied voltage of up to 5,000 volts.
5. The method of claim 4 , wherein one or more pulses of the plurality of electrical pulses is configured to have a pulse length of at least 1 microsecond.
6. The method of claim 1 , further comprising:
maintaining a temperature of the target zone at 50 degrees Celsius or less.
7. The method of claim 1 , wherein the agent is delivered intravenously to the patient.
8. The method of claim 7 , wherein the agent is transferred to the target zone through the disrupted blood-brain-barrier.
9. The method of claim 1 , wherein the agent comprises one or more of gadolinium, contrast, chemotherapeutic agent, bioactive agents, anti-cancer drugs, cytotoxic proteins, single or multi-walled carbon nanotubes, conductive gels, antibiotics, anti-inflammatories, anesthetics, muscle relaxers, and/or nerve relaxers.
10. A method for treating brain tissue comprising:
inserting a probe into a target zone of a patient, wherein the probe comprises at least one electrode;
selecting a pulse parameter setting for delivering a plurality of electrical pulses through the at least one electrode, wherein the plurality of electrical pulses are configured to create an irreversible electroporation (IRE) decellularization zone causing a disruption of a blood-brain-barrier to the IRE decellularization zone, and wherein the pulse parameter setting is comprised of selecting at least one pulse having a positive polarity and selecting at least one pulse having a negative polarity.
11. The method of claim 10 , wherein one or more pulse of the plurality of electrical pulses is configured to have an applied voltage up to 5,000 volts.
12. The method of claim 11 , wherein one or more pulse of the plurality of electrical pulses has a length of at least 1 microsecond.
13. The method of claim 10 , further comprising delivering an agent intravenously to the patient such that the agent is transferred to the target zone through the disrupted blood-brain-barrier.
14. The method of claim 10 , further comprising:
monitoring for a change in electrical impedance in real time; and
adjusting a current of the electrical pulses in real time based on a monitored change in electrical impedance.
15. A method for treating brain tissue comprising:
inserting a probe into a target zone of a patient, wherein the probe comprises at least one electrode;
applying a plurality of electrical pulses through the at least one electrode, wherein one or more of the electrical pulses has a pulse length of at least 1 microsecond; wherein the plurality of electrical pulses are configured to create an irreversible electroporation (IRE) decellularization zone causing a disruption of a blood-brain-barrier to the IRE decellularization zone; and
promoting a beneficial immune response as a result of the IRE.
16. The method of claim 15 , wherein the plurality of electrical pulses are configured such that at least one pulse has a positive polarity and at least one pulse has a negative polarity.
17. The method of claim 16 , wherein one or more of the plurality of electrical pulses are configured to have an applied voltage up to 5,000 volts.
18. The method of claim 16 , further comprising delivering an agent to the patient and allowing the agent to be transferred to the target zone through the disrupted blood-brain-barrier.
19. The method of claim 15 , wherein the disruption of the blood-brain-barrier extends beyond the IRE decellularization zone.
20. The method of claim 15 , further comprising monitoring for a change in electrical impedance of the target zone in real-time.